Personalized microbiota therapy in clinical medicine

Project manager: Johannes Hov
 
The strategic research area “Personalized microbiota therapy in clinical medicine” establishes a multidisciplinary team at Oslo University Hospital, which will plan, coordinate and perform human trials of microbiota therapy. Clinical medicine based on stratification or modification of gut microbial composition requires gastroenterologists, infectious disease specialists, microbiologist and specialists in the individual diseases. Recently funded trials in primary C. difficile colitis, systemic sclerosis, HIV infection and cardiovascular disease highlight the potential and the need for a joint research strategy to enable rapid clinical translation and improved patient care within many fields, including inflammatory and infectious diseases as well as immune therapy for cancer.
 
Home page in Norwegian:
 
 
 
 
Scroll to top